[ad_1] NEW YORK, Jan. 1, 2026 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of VirTra, Inc. (“VirTra” or the “Company”) (NASDAQ: VTSI). Such investors are advised to contact Danielle Peyton at […]

[ad_1] NEW YORK, Jan. 1, 2026 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Duluth Holdings Inc. (“Duluth” or the “Company”) (NASDAQ: DLTH). Such investors are advised to contact Danielle Peyton at […]

[ad_1] NEW YORK, Jan. 1, 2026 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of  ADC Therapeutics SA (“ADC Therapeutics” or the “Company”) (NYSE: ADCT). Such investors are advised to contact Danielle Peyton […]

[ad_1] NEW YORK, Jan. 1, 2026 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS). Such investors are advised to contact Danielle Peyton at [email protected] or […]

[ad_1] NEW YORK, Jan. 1, 2026 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of  Ventyx Biosciences, Inc. (“Ventyx” or the “Company”) (NASDAQ: VTYX). Such investors are advised to contact Danielle Peyton at […]